Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Mikus

Showing results (131-140 of 194) with videos related to

Pageof 20
Sort By:
British Journal of Clinical Pharmacology|December 21, 2002
Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphineIngolf Meineke, Stefan Freudenthaler, Ute Hofmann, et al.
Antimicrobial Agents and Chemotherapy|April 7, 2010
Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltrationVerena Hafner, David Czock, Jürgen Burhenne, et al.
European Journal of Clinical Pharmacology|February 5, 2005
Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m)Michael Streit, Christoph Göggelmann, Christoph Dehnert, et al.
European Journal of Clinical Pharmacology|June 2, 2011
Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based methodEleni Aklillu, Sabina Mugusi, Eliford Ngaimisi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 29, 2005
Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mgRaoul Bergner, Martin Hoffmann, Klaus-Dieter Riedel, et al.
Therapeutic Innovation & Regulatory Science|February 4, 2021
How to Interpret an Investigator's Brochure for Meaningful Risk Assessment: Results of an AGAH Discussion ForumJens Rengelshausen, Kerstin Breithaupt-Groegler, Frank Donath, et al.
British Journal of Clinical Pharmacology|June 7, 2013
Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteersChristoph Markert, Yvonne Schweizer, Regina Hellwig, et al.
British Journal of Clinical Pharmacology|May 22, 2020
Midazolam microdosing applied in early clinical development for drug-drug interaction assessmentSabrina T Wiebe, Andreas Huennemeyer, Werner Kadus, et al.
Clinical Pharmacology and Therapeutics|July 9, 2005
Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokineticsJens Rengelshausen, Maria Banfield, Klaus-Dieter Riedel, et al.
Clinical Pharmacology and Therapeutics|October 17, 2020
Perspectives on Model-Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and RecommendationsFranziska Kluwe, Robin Michelet, Anna Mueller-Schoell, et al.
Pageof 20

Showing results (131-140 of 194) with videos related to

Sort By:
Pageof 20
British Journal of Clinical Pharmacology|December 21, 2002
Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphineIngolf Meineke, Stefan Freudenthaler, Ute Hofmann, et al.
Antimicrobial Agents and Chemotherapy|April 7, 2010
Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltrationVerena Hafner, David Czock, Jürgen Burhenne, et al.
European Journal of Clinical Pharmacology|February 5, 2005
Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m)Michael Streit, Christoph Göggelmann, Christoph Dehnert, et al.
European Journal of Clinical Pharmacology|June 2, 2011
Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based methodEleni Aklillu, Sabina Mugusi, Eliford Ngaimisi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 29, 2005
Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mgRaoul Bergner, Martin Hoffmann, Klaus-Dieter Riedel, et al.
Therapeutic Innovation & Regulatory Science|February 4, 2021
How to Interpret an Investigator's Brochure for Meaningful Risk Assessment: Results of an AGAH Discussion ForumJens Rengelshausen, Kerstin Breithaupt-Groegler, Frank Donath, et al.
British Journal of Clinical Pharmacology|June 7, 2013
Clarithromycin substantially increases steady-state bosentan exposure in healthy volunteersChristoph Markert, Yvonne Schweizer, Regina Hellwig, et al.
British Journal of Clinical Pharmacology|May 22, 2020
Midazolam microdosing applied in early clinical development for drug-drug interaction assessmentSabrina T Wiebe, Andreas Huennemeyer, Werner Kadus, et al.
Clinical Pharmacology and Therapeutics|July 9, 2005
Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokineticsJens Rengelshausen, Maria Banfield, Klaus-Dieter Riedel, et al.
Clinical Pharmacology and Therapeutics|October 17, 2020
Perspectives on Model-Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and RecommendationsFranziska Kluwe, Robin Michelet, Anna Mueller-Schoell, et al.
Pageof 20